Literature DB >> 26701959

Hip fracture risk in patients with dementia in German primary care practices.

Jens Bohlken1, Louis Jacob2, Peter Schaum3, Michael A Rapp4, Karel Kostev5.   

Abstract

The aim was to analyze the risk of hip fracture in German primary care patients with dementia. This study included patients aged 65-90 from 1072 primary care practices who were first diagnosed with dementia between 2010 and 2013. Controls were matched (1:1) to cases for age, sex, and type of health insurance. The primary outcome was the diagnosis of hip fracture during the three-year follow-up period. A total of 53,156 dementia patients and 53,156 controls were included. A total of 5.3% of patients and 0.7% of controls displayed hip fracture after three years. Hip fracture occurred more frequently in dementia subjects living in nursing homes than in those living at home (9.2% versus 4.3%). Dementia, residence in nursing homes, and osteoporosis were risk factors for fracture development. Antidementia, antipsychotic, and antidepressant drugs generally had no significant impact on hip fracture risk when prescribed for less than six months. Dementia increased hip fracture risk in German primary care practices.

Entities:  

Keywords:  dementia; hip fracture; nursing homes; osteoporosis; risk factors

Mesh:

Year:  2015        PMID: 26701959     DOI: 10.1177/1471301215621854

Source DB:  PubMed          Journal:  Dementia (London)        ISSN: 1471-3012


  3 in total

1.  Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.

Authors:  S Dombrowski; L Jacob; P Hadji; K Kostev
Journal:  Osteoporos Int       Date:  2017-04-13       Impact factor: 4.507

2.  Visit-to-visit blood pressure variability and hip fracture: response to comments by Nagai et al.

Authors:  T-C Li; C-C Lin
Journal:  Osteoporos Int       Date:  2019-04-02       Impact factor: 4.507

3.  Clinical Characteristics of Primary and Secondary Osteoporotic Fractures: Data from Single Referral Center Emergency Department.

Authors:  Jung Yun Choi; Sung Min Park
Journal:  J Bone Metab       Date:  2019-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.